Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function [clinicaltrials:NCT00002901]
Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function [clinicaltrials:NCT00002901]
Bio2RDF identifier
NCT00002901
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00002901
identifiers.org URI
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
RATIONALE: Drugs used i ...... s no
effective therapy.
brief title [clinicaltrials_vocabulary:brief-title]
Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function
collaborator [clinicaltrials_vocabulary:collaborator]
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
OBJECTIVES: I. Determin ...... dy within 12-18
months.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
1999-11-01T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
keyword [clinicaltrials_vocabulary:keyword]
borderline ovarian surface epithelial-stromal tumor
ovarian sarcoma
ovarian stromal cancer
recurrent adenoid cystic carcinoma of the oral cavity
recurrent basal cell carcinoma of the lip
recurrent breast cancer
recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
recurrent inverted papilloma of the paranasal sinus and nasal cavity
recurrent lymphoepithelioma of the nasopharynx
recurrent lymphoepithelioma of the oropharynx
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2010-01-11T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
link [clinicaltrials_vocabulary:link]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00002901
official title [clinicaltrials_vocabulary:official-title]
PHASE I STUDY OF TAXOTERE IN P ...... G DEGREES OF LIVER DYSFUNCTION
org study id [clinicaltrials_vocabulary:org-study-id]
CDR0000065241
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
secondary id [clinicaltrials_vocabulary:secondary-id]
U01CA062505
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
1996-12-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2010-01-01T00:00:00Z
identifier
clinicaltrials:NCT00002901
title
Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function
@en
type
label
Docetaxel in Treating Patients ...... n [clinicaltrials:NCT00002901]
@en